Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shoval Tirman"'
Autor:
Shafrira Shai, Fernando Patolsky, Hagai Drori, Eyal J. Scheinman, Eyal Davidovits, Giora Davidovits, Shoval Tirman, Nadir Arber, Amit Katz, Yochai Adir
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Introduction Lung cancer remains the leading cause of death from cancer, worldwide. Developing early detection diagnostic methods, especially non-invasive methods, is a critical component to raising the overall survival rate and prognosis fo
Externí odkaz:
https://doaj.org/article/8562ce971b2e4f8ea60676118c73fc7f
Autor:
Irit Arbel, Shoval Tirman, Fernando Patolsky, Michal Shteinberg, Eyal Davidovits Davidovits, Giora Davidovits, Sonia Schneer, Yochai Adir
Publikováno v:
Lung Cancer.
Introduction: Early diagnosis of lung cancer is a key for improving prognosis. We present an innovative, non-invasive, Liquid ImmunoBiopsy assay for lung cancer detection based on measurements of the metabolic activity profiles (MAPs) of immune syste
Publikováno v:
Nucleic Acids Research
The identification of the molecular pathways active in specific contexts, such as disease states or drug responses, often requires an extensive view of the potential interactions between a subset of proteins. This view is not easily obtained: it requ
Autor:
Giora Davidovits, Aviv Lutaty, Cynthia Botbol, Irit Arbel, Hagit Peretz Soroka, Tali Scheinmann, Shoval Tirman, Ruven Tirosh, Sonia Schneer, Michal Shteinberg, Shirley Abramovitch, Yochai Adir, Fernando Patolsky, Eyal Davidovits Davidovits
Publikováno v:
Cancer immunology, immunotherapy : CII. 67(7)
Lung cancer is the leading cause of cancer death worldwide. Survival is largely dependent on the stage of diagnosis: the localized disease has a 5-year survival greater than 55%, whereas, for spread tumors, this rate is only 4%. Therefore, the early
Publikováno v:
Nucleic Acids Research
Genome sequencing and transcriptomic profiling are two widely used approaches for the identification of human disease pathways. However, each approach typically provides a limited view of disease pathways: Genome sequencing can identify disease-relat